Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
177 articles
New research reveals vitamin D supplements dramatically reduce dementia risk, even for those genetically predisposed to Alzheimer's disease.
Researchers finally discovered how lecanemab clears brain plaques by activating immune cells through a specific antibody fragment.
Researchers discover toxic protein pair that kills brain cells in Alzheimer's and develop compound to block it in mice.
Five large studies reveal dairy as the strongest dietary risk factor for Parkinson's disease, with potential brain cell damage mechanisms identified.
New p-tau217 blood test forecasts Alzheimer's symptoms within 3-4 years, potentially revolutionizing early intervention strategies.
Simple scans measuring brain blood flow and oxygen levels could detect Alzheimer's risk earlier than current methods by focusing on vascular health.
UK study of 165,000 dementia patients finds risperidone increases stroke risk across all groups, challenging safety assumptions.
New research reveals five ways microscopic plastic particles could damage brain health and accelerate neurodegenerative diseases.
Researchers finally discovered lecanemab activates brain immune cells through a specific antibody fragment to clear toxic plaques.
Moderate caffeine intake from coffee or tea linked to better brain health and slower cognitive decline in massive long-term study.
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Study tests VR therapy versus traditional cognitive training in 60 patients with mild cognitive impairment and Alzheimer's disease.
